Investigational drug shows promise in ovarian cancer

Monday, September 15, 2008 - 17:21 in Health & Medicine

An investigational drug that combats ovarian cancer by inhibiting the formation of new blood vessels has shown promise in a phase II trial, according to a presentation at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.

Read the whole article on Biology News Net

More from Biology News Net

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net